JP2022517842A5 - - Google Patents

Info

Publication number
JP2022517842A5
JP2022517842A5 JP2021542307A JP2021542307A JP2022517842A5 JP 2022517842 A5 JP2022517842 A5 JP 2022517842A5 JP 2021542307 A JP2021542307 A JP 2021542307A JP 2021542307 A JP2021542307 A JP 2021542307A JP 2022517842 A5 JP2022517842 A5 JP 2022517842A5
Authority
JP
Japan
Prior art keywords
transformation
approximately
diffraction pattern
manufacturing
cukα
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021542307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/050544 external-priority patent/WO2020152629A1/en
Publication of JP2022517842A publication Critical patent/JP2022517842A/ja
Publication of JP2022517842A5 publication Critical patent/JP2022517842A5/ja
Priority to JP2024074242A priority Critical patent/JP2024099797A/ja
Pending legal-status Critical Current

Links

JP2021542307A 2019-01-23 2020-01-23 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 Pending JP2022517842A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024074242A JP2024099797A (ja) 2019-01-23 2024-05-01 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962795799P 2019-01-23 2019-01-23
US62/795,799 2019-01-23
PCT/IB2020/050544 WO2020152629A1 (en) 2019-01-23 2020-01-23 New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024074242A Division JP2024099797A (ja) 2019-01-23 2024-05-01 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態

Publications (2)

Publication Number Publication Date
JP2022517842A JP2022517842A (ja) 2022-03-10
JP2022517842A5 true JP2022517842A5 (cg-RX-API-DMAC7.html) 2023-02-01

Family

ID=69467591

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021542307A Pending JP2022517842A (ja) 2019-01-23 2020-01-23 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態
JP2024074242A Pending JP2024099797A (ja) 2019-01-23 2024-05-01 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024074242A Pending JP2024099797A (ja) 2019-01-23 2024-05-01 7-シクロペンチル-2-(5-ピペラジン-1-イル-ピリジン-2-イルアミノ)-7H-ピロロ[2,3-d]ピリミジン-6-カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態

Country Status (8)

Country Link
US (2) US12390468B2 (cg-RX-API-DMAC7.html)
EP (1) EP3914353A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022517842A (cg-RX-API-DMAC7.html)
CN (1) CN113316471A (cg-RX-API-DMAC7.html)
AU (2) AU2020211071A1 (cg-RX-API-DMAC7.html)
CA (1) CA3124015A1 (cg-RX-API-DMAC7.html)
IL (1) IL284510B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020152629A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002123A (es) 2017-08-25 2020-09-18 Sicor Soc It Corticosteroidi S R L Sales de ribociclib y formas en estado sólido de las mismas.
WO2020152629A1 (en) 2019-01-23 2020-07-30 Novartis Ag New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide
EP4626890A1 (en) 2022-12-01 2025-10-08 KRKA, d.d., Novo mesto Ribociclib salts and formulations thereof
EP4762058A1 (en) * 2023-08-18 2026-06-24 Alembic Pharmaceuticals Limited Polymorph of ribociclib salt
WO2025144118A1 (en) * 2023-12-27 2025-07-03 Deva Holding Novel polymorph of ribociclib dihydrochloride dihydrate and method of preparation
US20250319032A1 (en) 2024-04-15 2025-10-16 Novartis Ag Pharmaceutical compositions of ribociclib

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI992711A1 (it) 1999-12-27 2001-06-27 Novartis Ag Composti organici
EA012926B1 (ru) 2001-12-20 2010-02-26 Оси Фармасьютикалз, Инк. Пирролопиримидиновые соединения, относящиеся к a-селективным антагонистам, их синтез и применение
SG146624A1 (en) 2003-09-11 2008-10-30 Kemia Inc Cytokine inhibitors
JP2008506761A (ja) 2004-07-22 2008-03-06 アステックス、セラピューティックス、リミテッド プロテインキナーゼ阻害剤としてのチアゾールおよびイソチアゾール誘導体
BRPI0612997A2 (pt) 2005-07-22 2010-12-14 Qualcomm Incorporated dispositivos mems e respectivos mÉtodos de fabrico
WO2007075783A2 (en) 2005-12-22 2007-07-05 Wyeth Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
TWI398252B (zh) 2006-05-26 2013-06-11 諾華公司 吡咯并嘧啶化合物及其用途
AU2009284098B2 (en) 2008-08-22 2012-03-29 Astex Therapeutics Ltd. Pyrrolopyrimidine compounds as CDK inhibitors
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR083797A1 (es) 2010-11-10 2013-03-20 Novartis Ag Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos
TW201636330A (zh) 2011-05-24 2016-10-16 拜耳知識產權公司 含有硫醯亞胺基團之4-芳基-n-苯基-1,3,5-三氮雜苯-2-胺
ES2910444T3 (es) 2012-02-24 2022-05-12 Nokia Technologies Oy Método y aparato para establecer una conexión con una red de acceso basándose en información de interfuncionamiento de red de acceso
CN105111215B (zh) * 2014-12-12 2019-06-18 苏州晶云药物科技股份有限公司 一种周期蛋白依赖性激酶抑制剂的晶型及其制备方法
US10138250B2 (en) 2014-12-12 2018-11-27 Crystal Pharmatech Co., Ltd. Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
WO2016091221A1 (zh) 2014-12-12 2016-06-16 苏州晶云药物科技有限公司 吡咯并[2,3-d]嘧啶化合物的盐及盐的新晶型
US10323035B2 (en) 2015-04-01 2019-06-18 Crystal Pharmatech Co., Ltd. Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof
MX2020002123A (es) 2017-08-25 2020-09-18 Sicor Soc It Corticosteroidi S R L Sales de ribociclib y formas en estado sólido de las mismas.
WO2019111160A1 (en) 2017-12-04 2019-06-13 Sun Pharmaceutical Industries Limited Crystalline forms of ribociclib succinate
WO2019123364A1 (en) 2017-12-22 2019-06-27 Shilpa Medicare Limited Novel polymorphs of ribociclib mono succinate
WO2019142206A1 (en) 2018-01-20 2019-07-25 Natco Pharma Limited An improved process for the preparation of ribociclib succinate and its novel crystalline forms thereof
TWI675662B (zh) * 2018-05-17 2019-11-01 中化合成生技股份有限公司 瑞博西尼琥珀酸鹽(Ribociclib succinate salt)晶型B、C及D與其衍生物,以及其等之製造方法與藥物組合物
WO2020152629A1 (en) 2019-01-23 2020-07-30 Novartis Ag New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide

Similar Documents

Publication Publication Date Title
TWI670270B (zh) 包含jak抑制劑之醫藥組合物
JP5684192B2 (ja) トリアゾロ[4,5−d]ピリミジン化合物の新規な結晶形及び非晶形
US20090247532A1 (en) Crystalline polymorph of sitagliptin phosphate and its preparation
JP2022530441A (ja) 7h-ピロロ[2,3-d]ピリミジンjak-阻害剤
AU2023200724B2 (en) New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide
TW200827356A (en) Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
CN101253176B (zh) 哒嗪并[4,5-b]吲哚衍生物的新晶形
CN104010636A (zh) 三环化合物、包含它们的组合物及其用途
JP2026041824A (ja) テガビビントの結晶形態、調製方法、及びその使用
JP7168447B2 (ja) ビラスチンの結晶形態及びそれらの調製方法
CN104098570A (zh) 替卡格雷晶型及其制备方法和用途
CN114057823B (zh) 白桦脂酸衍生物,其制备方法、药物组合物和应用
JP2004504390A (ja) (r)−n−[5−メチル−8−(4−メチルピペラジン−1−イル)−1,2,3,4−テトラヒドロ−2−ナフチル]−4−モルホリノベンズアミドの新規な形態
TWI751220B (zh) 一種GnRH受體拮抗劑的多晶型及其製備方法
EP1844017A1 (en) An amorphous and three crystalline forms of rimonabant hydrochloride
WO2012055163A1 (zh) 来曲唑i型结晶及其制备方法
RU2021124673A (ru) Новые кристаллические формы сукцинатной соли диметиламида 7-циклопентил-2-(5-пиперазин-1-илпиридин-2-иламино)-7h-пирроло[2,3-d]пиримидин-6-карбоновой кислоты
TWI902254B (zh) 化合物8-氯-3-戊基-3,7-二氫-1h-嘌呤-2,6-二酮的晶型及其製備方法
JP2022532186A (ja) 非晶質のpi3k阻害剤及びこれを含有する医薬組成物
WO2024179463A1 (zh) 化合物8-氯-3-戊基-3,7-二氢-1h-嘌呤-2,6-二酮的晶型及其制备方法
WO2025203051A1 (en) Ribociclib succinate form c and process thereof
JP2001518088A (ja) 抗不整脈薬として有用なニトロベンズアミド
JP2024544772A (ja) Ret阻害剤であるセルペルカチニブの結晶形態aの調製方法
TWI330082B (en) Crystalline form of triazolo(4,5-d)pyrimidine compound and method of preparing the same
WO2025045072A1 (zh) 一种酞嗪酮类化合物及其制备方法、药物组合物及用途